James Hardie president sells 65K company shares
James Hardie Industries plc (JHX) reported insider equity transactions by Jonathan Skelly, President of James Hardie NA.
Rhea-AI Filing Summary
James Hardie Industries plc (JHX) reported insider equity transactions by Jonathan Skelly, President of James Hardie NA. On 2026-08-25 he exercised 50,000 employee stock options with an exercise price of $11.23 per share, which had been assumed in connection with the acquisition of The AZEK Company Inc. and were exercisable as of July 1, 2025. He then sold a total of 65,000 ordinary shares in open-market transactions at weighted average prices of approximately $30.45 and $30.46 per share, including 50,000 shares sold through a broker-assisted cashless exercise. Following the derivative transaction, he held 287,721 employee stock options directly.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Skelly Jonathan
Role
Pres. James Hardie NA
Sold
65,000 shs ($1.98M)
Approx. gross sale proceeds
$1.98M
Approx. exercise cost
$562K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F3 | 50,000 | $0.00 | $0.00 |
| Sale | Ordinary shares F1 | 15,000 | $30.45 | $457K |
| Exercise | Ordinary shares | 50,000 | $11.23 | $562K |
| Sale | Ordinary shares F2 | 50,000 | $30.46 | $1.52M |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 287,721 contracts (Direct);
Ordinary shares — 309,906 shares (Direct)
Footnotes (3)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.27 to $30.66 inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to the extent required by law.
- F2. Represents shares sold through a broker-assisted cashless exercise.
- F3. The options were exercisable as of July 1, 2025, when they were assumed by the issuer in connection with its acquisition of The AZEK Company Inc.
Key Figures
Options exercised: 50,000 employee stock options
Exercise price: $11.23 per share
Shares sold (weighted average $30.45): 15,000 ordinary shares
+5 more
8 metrics
Options exercised
50,000 employee stock options
Exercised on 2026-08-25 with an exercise price of $11.23 per share
Exercise price
$11.23 per share
Exercise price for 50,000 employee stock options converting into ordinary shares
Shares sold (weighted average $30.45)
15,000 ordinary shares
Sold on 2026-08-25 at a weighted average price of $30.45 per share
Shares sold (weighted average $30.46)
50,000 ordinary shares
Sold on 2026-08-25 at a weighted average price of $30.46 per share through broker-assisted cashless exercise
Total shares sold
65,000 ordinary shares
Aggregate ordinary shares sold by Jonathan Skelly on 2026-08-25
Remaining options
287,721 employee stock options
Total employee stock options held directly after the reported derivative transaction
Option expiration date
2030-06-16
Expiration date for the exercised employee stock option grant
Option exercisability date
July 1, 2025
Date options became exercisable after being assumed in The AZEK Company Inc. acquisition
Key Terms
Employee Stock Option (Right to Buy), broker-assisted cashless exercise, weighted average price, ordinary shares, +1 more
5 terms
Employee Stock Option (Right to Buy) financial
"security_title is reported as "Employee Stock Option (Right to Buy)" for the derivative"
broker-assisted cashless exercise financial
"Represents shares sold through a broker-assisted cashless exercise."
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Rule 10b5-1 regulatory
"aff_10b5_one is a document-level Rule 10b5-1 checkbox for trading plans"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did JHX executive Jonathan Skelly report in this Form 4 transaction?
Jonathan Skelly reported exercising 50,000 employee stock options at an exercise price of $11.23 per share and selling 65,000 ordinary shares of James Hardie Industries plc on 2026-08-25 in open-market transactions.
What options did Jonathan Skelly exercise in James Hardie (JHX)?
He exercised 50,000 employee stock options to acquire ordinary shares of JHX at an exercise price of $11.23 per share. These options were exercisable as of July 1, 2025 and were assumed by James Hardie in its acquisition of The AZEK Company Inc.
How many James Hardie (JHX) options does Jonathan Skelly hold after these transactions?
After the reported derivative transaction, Jonathan Skelly directly held 287,721 employee stock options of James Hardie Industries plc, according to the post-transaction balance reported for the option position.
Was the JHX Form 4 transaction under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is unchecked, and the footnotes do not state that the transactions were made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
